Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

EMA starts review of Pfizer and Merck's PD-L1 inhibitor

EMA starts review of Pfizer and Merck's PD-L1 inhibitor executive vice president, global head of R&D at the biopharma business of Merck. ... Pfizer paid Merck $850m upfront to jointly develop and market avelumab for multiple cancer indications in 2014.

Merck completes €15m Spanish biotech facility expansion

Merck completes €15m Spanish biotech facility expansion Merck has completed a 15m investment project at its biotech facility in Spain that will allow it to up production of its fertility and growth hormone disorder treatments by 50%. ... Simon Sturge, chief operating officer of Merck's biopharma business, said

Merck sees €2bn from new launches by 2022

Merck sees €2bn from new launches by 2022 Germany's Merck KGaA says its healthcare division will deliver a new product or indication every year between 2017 and 2022, which should generate new sales of around 2bn. ... We firmly believe that we will meet the objectives we have set for 2018,"

Merck KGaA appoints chief strategy officer

Merck KGaA appoints chief strategy officer Darmstadt, Germany-based Merck KGaA has appointed Isabel De Paoli to the newly-created role of chief strategy officer. ... De Paoli first joined Merck in 2006 as business development manager, chemicals before promotion to head of strategic planning

Shire gives up on Momenta-partnered Humira biosimilar

Shire gives up on Momenta-partnered Humira biosimilar Samsung Bioepis is in pole position in Europe having filed for approval of its SB5 biosimilar in July, while Sandoz, Merck KGaA and FujiFilm/Kyowa Hakko Kirin have candidates in phase

[ Previous 5 results ] 23 24 25 26 27 28 29 30 31 32 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...